Axcella health.

Axcella Health Inc. [ AXLA] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director: X: 10% Owner: Officer (give title below) Other (specify below) 3. Date of Earliest Transaction (Month/Day/Year) 03/16/2022: 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable …Aug 29, 2023 · Axcella Health (NASDAQ: AXLA) stock surged by as much as 280% on news that it has been granted an important new patent. Today, the U.S. Patent and Trademark Office (USPTO) granted the biotech ... Revenue: Less than $1 million (USD) Biotech & Pharmaceuticals. Competitors: Unknown. Axcella is a clinical-stage biotechnology company pioneering a new approach to treat …১২ এপ্রি, ২০১৯ ... Axcella Health Inc. has filed for an IPO with the U.S. Securities and Exchange Commission to list its shares on the Nasdaq Global Market under ...

He is also on the board of Axcella Health, Inc. and President for ModernaTX, Inc. In his past career he was Partner at McKinsey & Co., Inc. He received an undergraduate degree from Amherst College and a doctorate from The University of California, San Francisco. Currently, Stephen Hoge occupies the position of President at Moderna, Inc. and ...Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and ... Aug 29, 2023 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Aug. 29, 2023-- Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic modulators (EMMs), today announced that the U.S. Patent and Trademark Office (USPTO) has ...

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Axcella Health (NASDAQ: AXLA) stock should jump 2,500% at the open. AXLA stock is not going to rise 25x as a part of the unusual price movements we’ve been seeing this past few weeks - this is a purely nominal price change, one designed to solve a particular problem. That problem is how to maintain the Nasdaq listing in the face of a low ...

Sep 21, 2023 · With five hospitals, nearly 1,000 healthcare providers and more than 7,000 employees, Independence Health System serves a ten county region and is the largest employer in Butler and Westmoreland counties. Created by the joining of two independent healthcare systems -- Butler Health System and Excela Health -- Independence Health System provides ... The study was approved by the Health Research Authority Fast Track research ethics committee (REC) (REC Reference: 21/FT/0158) and the United Kingdom Medicines and Healthcare Products Regulatory Authority (MHRA) (reference number: CTA 54043/0003/001-0001). ... JP, KA, DK are employees of Axcella Therapeutics and hold …Axcella (AXLA) shares surge 299% after the company secures a methods-of-use patent for its lead candidate, AXA1125, which is currently under development to treat fatigue associated with Long Covid.Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and ...

Dec 4, 2023 · AXLA Earnings Date and Information. Axcella Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 28th, 2023 based off prior year's report dates.

CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Aug. 29, 2023-- Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic modulators (EMMs), today announced that the U.S. Patent and Trademark Office (USPTO) has ...

Dec 15, 2022 · Axcella Health Inc. 1.0550 +0.0740 +7.54%: TRENDING. 1. Japan's Nikkei sinks to 3-week low as stronger yen hurts autos. 2. AI defined 2023. Bullets and ballots will shape 2024. 3. Aug 29, 2023 · Axcella Health (NASDAQ: AXLA) stock surged by as much as 280% on news that it has been granted an important new patent. Today, the U.S. Patent and Trademark Office (USPTO) granted the biotech ... A health information exchange, also known as an HIE, is set up as a way for patients and their health care providers to digitally share and access a patient’s medical information, according to HealthIT.gov.Sure, your fingernails might require a lot of upkeep, but did you know that they can actually tell you a lot about your health? While the look or texture of your fingernails isn’t a surefire way to diagnose all conditions, their appearance ...Dec. 15, 2022 7:13 AM ET Axcella Health Inc. (AXLA) By: Ravikash, SA News Editor 5 Comments. Andrii Yalanskyi. Axcella Therapeutics ( NASDAQ: AXLA) said it is exploring strategic alternatives and ...

Axcella Health, Inc. is a biotechnology company. It engages in the research and development of treatment for diseases and improves health using endogenous metabolic modulator, or EMM, and compositions. Its product pipeline includes AXA1665, for the reduction in risk of recurrent overt hepatic encephalopathy, and AXA1125, for non …Axcella Health Inc. is a clinical-stage biotechnology company. The Company is focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with simultaneously impacting multiple ...Axcella Health Inc. understands the significance of setting the right price, as it can either attract or deter potential customers. With this in mind, the company carefully considers various factors such as development costs, distribution expenses, research and marketing investments, and manufacturing costs when determining the optimal price ...Jun 30, 2021 · Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions. Aug 29, 2023 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)--Aug. 29, 2023-- Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic modulators (EMMs), today announced that the U.S. Patent and Trademark Office (USPTO) has ...

Promising Phase 2a results were announced by the company Axcella Health in the third quarter of 2022 for its trial of AXA1125 which targeted fatigue predominant long COVID . This small randomized, double-blind, placebo-controlled trial showed significant improvements in fatigue, as measured by the Chalder Fatigue Questionnaire eleven-item …

Axcella Therapeutics, a clinical-stage biotechnology company focused on pioneering a new approach to address the biology of complex diseases using compositions of endogenous metabolic modulators ...Axcella Health, Inc: ClinicalTrials.gov Identifier: NCT05152849 Other Study ID Numbers: AXA1125-201 : First Posted: December 10, 2021 Key Record Dates: Last Update Posted: October 20, 2022 Last Verified: November 2021Axcella Health Inc (AXLA) is expected to report for 3Q. Best Buy Co Inc (BBY) is expected to report $1.19 for 3Q. Broadway Financial Corp (BYFC) is expected to report for 3Q. Burlington Stores Inc (BURL) is expected to report $0.96 for 3Q. Caleres Inc (CAL) is expected to report $1.28 for 3Q. Chico's FAS Inc (CHS) is expected to report …Long COVID Axcella Health Flagship Pioneering COVID-19. Behind the unrelenting challenges of long COVID, which leaves many of the disease’s sufferers with exhaustion, sleep problems and brain ...Axcella Health, Inc. ClinicalTrials.gov Identifier: NCT04880187 History of Changes. Other Study ID Numbers: AXA1125-101. First Posted: May 10, 2021 Key Record ...AXCELLA HEALTH INC. Annual Meeting of Stockholders. September 11, 2023. RULES OF CONDUCT AND PROCEDURES. All stockholders in attendance at the 2023 Annual ...You are invited to attend a special meeting of stockholders (the “Special Meeting”) of Axcella Health Inc., a Delaware corporation (“Axcella”), which will be held on [•], 2023 at [•] a.m. Eastern Time, as it may be adjourned or postponed from time to time. Our Special Meeting will be held in a virtual-only format.Source Headline; Axcella Health Inc AXLA morningstar.com - November 7 at 11:55 PM: Axcella Health (AXLA) Price Target Increased by 7971.00% to 15,870.09 msn.com - November 1 at 9:16 AM: Pre-market Movers: RLMD, BROG, VSME, AXLA, NKE… markets.businessinsider.com - September 29 at 7:04 AM marketbeat.com - …AXCELLA HEALTH INC. 2019 EMPLOYEE STOCK PURCHASE PLAN . The purpose of the Axcella Health Inc. 2019 Employee Stock Purchase Plan (“the Plan”) is to provide eligible employees of Axcella Health Inc. (the “Company”) and each Designated Subsidiary (as defined in Section 11) with opportunities to purchase shares of the Company’s …Axcella Health has an overall rating of 3.9 out of 5, based on over 27 reviews left anonymously by employees. 80% of employees would recommend working at Axcella Health to a friend and 65% have a positive outlook for the business. This rating has been stable over the past 12 months.

Nov 30, 2023 · 2 brokerages have issued twelve-month price objectives for Axcella Health's stock. Their AXLA share price targets range from $50.00 to $50.00. On average, they anticipate the company's stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 1,462.5% from the stock's current price.

The following insiders have sold AXLA shares in the last 24 months: Margaret Koziel ($2,870.25), and William Hinshaw ($52,308.75). How much insider selling is happening at Axcella Health? Insiders have sold a total of 1,374 Axcella Health shares in the last 24 months for a total of $55,179.00 sold.

The First Health Network is a group of providers that accept First Health insurance and provide services to members at reduced rates, according to the First Health website. More than two million members use the First Health Network to meet ...With the internet at our fingertips, it can be very tempting to google our health concerns and get an immediate answer. After all, who has time to make a doctors appointment and spend hours sitting in a waiting room.6 Axcella Health Inc., 840 Memorial Drive, Cambridge, MA, 02139, USA. [email protected]. PMID: 34088912 PMCID: PMC8178416 DOI: 10.1038/s41598-021-88913-1 Abstract Nonalcoholic steatohepatitis (NASH) is a complex metabolic disease of heterogeneous and multifactorial pathogenesis that may benefit from coordinated …Aug 3, 2023 · Axcella’s proprietary composition of amino acids in AXA1125 in Long COVID fatigue is potentially an important step to help people maintain health after recovering from acute COVID-19," said Bill ... View the latest Axcella Health Inc. (AXLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Long COVID Axcella Health Flagship Pioneering COVID-19. Behind the unrelenting challenges of long COVID, which leaves many of the disease’s sufferers with exhaustion, sleep problems and brain ...Axcella will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, January 24, 2023. To access the live conference call, please dial 844-808-7139 (domestic) or 412-902-0127 ...Taking care of your mental health is equally as important as taking care of your physical health. Those living with a mental illness or disorder — whether ongoing or temporary — often find that it affects many areas of their life, including...Axcella Health Inc. is a clinical-stage biotechnology company. The Company is focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with simultaneously impacting multiple ...

Contact Email [email protected]. Phone Number +1 617 441 6243. Axcella is a clinical-stage biotechnology company that treats complex diseases using endogenous metabolic modulator (EMM) compositions. They combine biological pathways with developments in systems biology and machine learning. Their proprietary platform is clinically validated ...Exhibit 3.1 . CERTIFICATE OF AMENDMENT . TO . RESTATED CERTIFICATE OF INCORPORATION . OF . AXCELLA HEALTH INC. Axcella Health Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “Corporation”), does hereby certify as follows:Apr 13, 2021 · Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions. Instagram:https://instagram. how much is the half dollar coin worthhow does a rebuilt title affect insuranceinuvo stocktbf ticker Insider Ownership of Axcella Health. Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our information indicates that Axcella Health insiders own about US$839k worth of shares.The current stock performance of Axcella Health shows a 52-week-high of $6.84 and a 52-week-low of $3.03. Moreover, at the end of the last trading period, the closing price was at $3.60. transfer 529stock pbr Jan 6, 2022 · About Axcella Therapeutics (Nasdaq: AXLA) Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions. best trading algorithm Axcella Health (NASDAQ: AXLA) stock is rocketing higher on Tuesday after revealing a regulatory path to registration for AXA1125. Investors will note that AXA1125 is the company’s treatment for ...A health appraisal, or health risk assessment, is a tool that allows health providers to gather information about an individual’s physical health and lifestyle.